Massachusetts · 194th Legislature (2025-2026) · Bill
S 3068: An Act protecting patient safety regarding non-FDA approved drugs
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 3068 is a bill introduced in the Massachusetts Senate on May 26, 2026. According to its official title, it concerns: An Act protecting patient safety regarding non-FDA approved drugs. Primary sponsor: Joint Committee on Health Care Financing. Most recent recorded action (May 26, 2026): Referred to the committee on Senate Ways and Means.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
The committee on Health Care Financing to whom was referred the Senate Bill protecting patient safety regarding non-FDA approved drugs (Senate, No. 1497), - reports, recommending that the same ought to pass with an amendment substituting a new draft with the same title (Senate, No. 3068).
Sponsors
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Joint Committee on Health Care Financing | Primary sponsor | Not applicable (committee) | — | — |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Referred to the committee on Senate Ways and Means
- Recommended new draft for S1497
- Reported from the committee on Health Care Financing